Harbour BioMed
Updated: March 19, 2026
Jingsong Wang, CEO
Country: China | Funding: $417.8M (+)
Founded: 2016
Website: https://www.harbourbiomed.com/
Harbour BioMed is a global biopharmaceutical company developing innovative therapeutics in the field of immuno-oncology and inflammatory diseases.
Founded: 2016
Website: https://www.harbourbiomed.com/
Harbour BioMed is a global biopharmaceutical company developing innovative therapeutics in the field of immuno-oncology and inflammatory diseases.
